Medtronic is upping the ante in patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic's InterStim device, an implanted ...

(BPT) - It was the everyday struggles that really got to Peggy Smith. Smith couldn’t even make it to the grocery store without stopping to find a bathroom, let alone enjoy activities with her family ...

In this episode, Mira Sahney, president of the Pelvic Health business at Medtronic, explains how incontinence is a debilitating condition that needs more attention and treatment. The company's ...

Axonics has won a victory in an ongoing patent dispute with Medtronic over neuromodulation technology. A jury in California federal court found that the Irvine, CA-based company didn’t infringe on ...

Minze Health NV signed a three-year agreement with Medtronic plc to bring its Minze Diary Pod, an app-controlled automated urine collection device, to markets across the EMEA region. The partnership ...

BROOKLYN CENTER, Minn. — Medtronic is giving a group of international VIPs a rare, behind the scenes tour of its operations this week. In this case, VIP stands for Very Important Patients. "This is ...

It’s finally over. Medtronic and Boston Scientific’s Axonics longstanding patent battle is finished. The companies settled the legal spat over patent infringements related to sacral neuromodulation ...

The FDA has approved an app-based smart programming device used to discreetly and easily control implants treating for overactive bladder (OAB), chronic fecal incontinence (FI) and non-obstructive ...

Medtech giants Boston Scientific and Medtronic are doubling down on bladder-control therapies, confirming this space as one of the sector’s fastest-growing battlegrounds. Australis Scientific is ...

As US medtech heavyweights pour billions into bladder-control therapies for ageing populations, an Australian company is emerging with a disruptive new solution. Medtech giants Boston Scientific and ...